MedPath

Affera, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:1

Trial Phases

1 Phases

Not Applicable:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
3 (100.0%)

Safety and Performance of the SpherePVI™ Catheter to Treat Paroxysmal Atrial Fibrillation

Not Applicable
Recruiting
Conditions
Atrial Fibrillation
First Posted Date
2021-12-03
Last Posted Date
2025-06-22
Lead Sponsor
Medtronic Cardiac Ablation Solutions
Target Recruit Count
50
Registration Number
NCT05144503
Locations
🇱🇹

Vilnius University Hospital, Vilnius, Lithuania

Treatment of Persistent Atrial Fibrillation With Sphere-9 Catheter and Affera Mapping and Ablation System

Not Applicable
Completed
Conditions
Atrial Fibrillation
First Posted Date
2021-11-15
Last Posted Date
2025-04-23
Lead Sponsor
Medtronic Cardiac Ablation Solutions
Target Recruit Count
477
Registration Number
NCT05120193
Locations
🇺🇸

Arrhythmia Institute at Grandview, Birmingham, Alabama, United States

🇺🇸

Banner University Medical Center Phoenix, Phoenix, Arizona, United States

🇺🇸

Arrhythmia Research Group, Jonesboro, Arkansas, United States

and more 20 locations

Safety and Performance of the Affera SpherePVI™ Multi-Ablation System to Treat Paroxysmal Atrial Fibrillation

Not Applicable
Recruiting
Conditions
Atrial Fibrillation
First Posted Date
2021-11-10
Last Posted Date
2025-06-22
Lead Sponsor
Medtronic Cardiac Ablation Solutions
Target Recruit Count
50
Registration Number
NCT05115214
Locations
🇨🇿

Homolka Hospital, Prague, Czechia

🇨🇿

Institute Klinicke a Experimentalni Mediciny, Praha, Czechia

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.